130 related articles for article (PubMed ID: 21384484)
1. Inhibition of influenza virus activity by multivalent glycoarchitectures with matched sizes.
Papp I; Sieben C; Sisson AL; Kostka J; Böttcher C; Ludwig K; Herrmann A; Haag R
Chembiochem; 2011 Apr; 12(6):887-95. PubMed ID: 21384484
[TBL] [Abstract][Full Text] [Related]
2. Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo.
Bhatia S; Lauster D; Bardua M; Ludwig K; Angioletti-Uberti S; Popp N; Hoffmann U; Paulus F; Budt M; Stadtmüller M; Wolff T; Hamann A; Böttcher C; Herrmann A; Haag R
Biomaterials; 2017 Sep; 138():22-34. PubMed ID: 28550754
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles.
Papp I; Sieben C; Ludwig K; Roskamp M; Böttcher C; Schlecht S; Herrmann A; Haag R
Small; 2010 Dec; 6(24):2900-6. PubMed ID: 21104827
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.
Reuter JD; Myc A; Hayes MM; Gan Z; Roy R; Qin D; Yin R; Piehler LT; Esfand R; Tomalia DA; Baker JR
Bioconjug Chem; 1999; 10(2):271-8. PubMed ID: 10077477
[TBL] [Abstract][Full Text] [Related]
5. Multivalent Flexible Nanogels Exhibit Broad-Spectrum Antiviral Activity by Blocking Virus Entry.
Dey P; Bergmann T; Cuellar-Camacho JL; Ehrmann S; Chowdhury MS; Zhang M; Dahmani I; Haag R; Azab W
ACS Nano; 2018 Jul; 12(7):6429-6442. PubMed ID: 29894156
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus activity by newly designed multivalent glycoarchitectures.
Papp I; Sieben C; Sisson AL; Herrmann A; Haag R
J Control Release; 2010 Nov; 148(1):e114-5. PubMed ID: 21529585
[No Abstract] [Full Text] [Related]
7. Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
Nie C; Parshad B; Bhatia S; Cheng C; Stadtmüller M; Oehrl A; Kerkhoff Y; Wolff T; Haag R
Angew Chem Int Ed Engl; 2020 Sep; 59(36):15532-15536. PubMed ID: 32421225
[TBL] [Abstract][Full Text] [Related]
8. Adaptive Flexible Sialylated Nanogels as Highly Potent Influenza A Virus Inhibitors.
Bhatia S; Hilsch M; Cuellar-Camacho JL; Ludwig K; Nie C; Parshad B; Wallert M; Block S; Lauster D; Böttcher C; Herrmann A; Haag R
Angew Chem Int Ed Engl; 2020 Jul; 59(30):12417-12422. PubMed ID: 32441859
[TBL] [Abstract][Full Text] [Related]
9. Multivalent Peptide-Nanoparticle Conjugates for Influenza-Virus Inhibition.
Lauster D; Glanz M; Bardua M; Ludwig K; Hellmund M; Hoffmann U; Hamann A; Böttcher C; Haag R; Hackenberger CPR; Herrmann A
Angew Chem Int Ed Engl; 2017 May; 56(21):5931-5936. PubMed ID: 28444849
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles.
Baram-Pinto D; Shukla S; Gedanken A; Sarid R
Small; 2010 May; 6(9):1044-50. PubMed ID: 20394070
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
12. Hyperbranched polyglycerols on the nanometer and micrometer scale.
Steinhilber D; Seiffert S; Heyman JA; Paulus F; Weitz DA; Haag R
Biomaterials; 2011 Feb; 32(5):1311-6. PubMed ID: 21047679
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Influenza Virus Envelope's Fusogenicity by Viral Fusion Inhibitors.
Rowse M; Qiu S; Tsao J; Yamauchi Y; Wang G; Luo M
ACS Infect Dis; 2016 Jan; 2(1):47-53. PubMed ID: 27622947
[TBL] [Abstract][Full Text] [Related]
14. Mucin-Inspired, High Molecular Weight Virus Binding Inhibitors Show Biphasic Binding Behavior to Influenza A Viruses.
Wallert M; Nie C; Anilkumar P; Abbina S; Bhatia S; Ludwig K; Kizhakkedathu JN; Haag R; Block S
Small; 2020 Nov; 16(47):e2004635. PubMed ID: 33135314
[TBL] [Abstract][Full Text] [Related]
15. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
16. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
Hidari KI; Murata T; Yoshida K; Takahashi Y; Minamijima YH; Miwa Y; Adachi S; Ogata M; Usui T; Suzuki Y; Suzuki T
Glycobiology; 2008 Oct; 18(10):779-88. PubMed ID: 18621993
[TBL] [Abstract][Full Text] [Related]
17. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate.
Baram-Pinto D; Shukla S; Perkas N; Gedanken A; Sarid R
Bioconjug Chem; 2009 Aug; 20(8):1497-502. PubMed ID: 21141805
[TBL] [Abstract][Full Text] [Related]
19. Multivalent presentation of mannose on hyperbranched polyglycerol and their interaction with concanavalin A lectin.
Papp I; Dernedde J; Enders S; Riese SB; Shiao TC; Roy R; Haag R
Chembiochem; 2011 May; 12(7):1075-83. PubMed ID: 21480454
[TBL] [Abstract][Full Text] [Related]
20. Highly Efficient Multivalent 2D Nanosystems for Inhibition of Orthopoxvirus Particles.
Ziem B; Thien H; Achazi K; Yue C; Stern D; Silberreis K; Gholami MF; Beckert F; Gröger D; Mülhaupt R; Rabe JP; Nitsche A; Haag R
Adv Healthc Mater; 2016 Nov; 5(22):2922-2930. PubMed ID: 27581958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
